BIOMARKERS, GENES, AND TARGETS Trademark

Trademark Overview

On Tuesday, June 24, 2025, a trademark application was filed for BIOMARKERS, GENES, AND TARGETS with the United States Patent and Trademark Office. The USPTO has given the BIOMARKERS, GENES, AND TARGETS trademark a serial number of 99251145. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Tuesday, April 7, 2026. This trademark is owned by Innovative Oncology Consulting, LLC. The BIOMARKERS, GENES, AND TARGETS trademark is filed in the Education & Entertainment Services category with the following description:

Arranging and conducting of educational conferences in the field of healthcare
biomarkers, genes, and targets

General Information

Serial Number99251145
Word MarkBIOMARKERS, GENES, AND TARGETS
Filing DateTuesday, June 24, 2025
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateTuesday, April 7, 2026
Registration Number0000000
Registration DateTuesday, April 28, 2026
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Pseudo MarkBIO MARKERS GENES AND TARGETS
Goods and ServicesArranging and conducting of educational conferences in the field of healthcare

Classification Information

International Class041 - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes100, 101, 107
Class Status Code6 - Active
Class Status DateTuesday, June 24, 2025
Primary Code041
First Use Anywhere DateFriday, September 19, 2025
First Use In Commerce DateFriday, September 19, 2025

Trademark Owner History

Party NameInnovative Oncology Consulting, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressDeerfield, IL 60015
US

Trademark Events

Event DateEvent Description
Tuesday, June 24, 2025NEW APPLICATION ENTERED
Tuesday, June 24, 2025APPLICATION FILING RECEIPT MAILED
Friday, October 31, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, November 13, 2025ASSIGNED TO EXAMINER
Friday, November 21, 2025NON-FINAL ACTION WRITTEN
Friday, November 21, 2025NON-FINAL ACTION E-MAILED
Friday, November 21, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, February 23, 2026TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, February 23, 2026CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, February 23, 2026TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, March 13, 2026FINAL REFUSAL WRITTEN
Friday, March 13, 2026FINAL REFUSAL E-MAILED
Friday, March 13, 2026NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, March 16, 2026TEAS AMENDMENT OF USE RECEIVED
Monday, March 16, 2026USE AMENDMENT FILED
Monday, March 16, 2026AMENDMENT TO USE PROCESSING COMPLETE
Monday, March 30, 2026USE AMENDMENT ACCEPTED
Monday, March 30, 2026EXAMINERS AMENDMENT -WRITTEN
Monday, March 30, 2026EXAMINERS AMENDMENT E-MAILED
Monday, March 30, 2026NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, March 30, 2026EXAMINER'S AMENDMENT ENTERED
Monday, March 30, 2026APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER

Related Keywords

targets genes biomarkers field healthcare conferences educational conducting arranging